Job cuts
Rani Therapeutics and Sangamo Cut Staff and Operations to Secure 2024 Viability
Rani Therapeutics and Sangamo Therapeutics are the latest biotech companies to implement substantial workforce reductions as part of their strategies ...
Pfizer Announces New Jersey Site Closure and Layoffs in $3.5B Cost-Cutting Initiative
The financial ramifications of Pfizer’s revenue decline due to the COVID-19 pandemic are now revealing their human toll as the ...
ElevateBio slashes 13% of workforce despite huge fundraising
Despite having a substantial $401 million in funding, ElevateBio is streamlining its operations, resulting in job cuts that will impact ...
Biogen cuts jobs at Reata after $2.95 billion deal for kidney drug rights
A mere fortnight after the completion of Biogen’s acquisition of Reata Pharmaceuticals, the newly merged entity is taking a scalpel ...
Fujifilm Irvine Scientific and Formulated Solutions announce over 50 layoffs each, according to filings
In the midst of a recent wave of workforce reductions within the biopharma sector, two contract manufacturers have implemented significant ...
Eikon announces layoffs as part of its restructuring plan to improve efficiency and profitability
Eikon Therapeutics, a biotechnology company that attracted top executives from Merck & Co. and secured substantial financing, has implemented staff ...
PTC cuts jobs as Europe withdraws approval for its DMD drug
PTC Therapeutics has announced an expansion of its previously planned workforce reductions as European regulatory concerns cast a shadow over ...
Galecto slashes workforce, explores options after failed fibrosis trial
Boston-based biotech firm Galecto is facing a significant workforce reduction of 70%, affecting 29 employees, following the discontinuation of its ...
AM-Pharma lays off staff and changes CEO after failed phase 3 trial of ilofotase alfa
After experiencing a setback in its phase 3 study for sepsis-associated acute kidney injury (SA-AKI), Dutch biotech company AM-Pharma is ...
ImmunityBio cuts 50 jobs in California and Florida after FDA snubs its bladder cancer drug
Following an FDA rejection earlier this year, ImmunityBio has initiated its second round of layoffs in less than a year, ...
Sana cuts jobs in research area, keeps mum on numbers and programs
Sana Biotechnology, a company with a focus on CAR-T therapies, has discreetly carried out another round of layoffs, declining to ...
Novartis Announces New Round of Layoffs at US Headquarters Following Earlier Job Cuts
Novartis, a Swiss pharmaceutical giant, is set to undergo another round of job cuts at its U.S. headquarters in East ...
